STOCK TITAN

Crexendo (CXDO) Form 4 Filings

CXDO NASDAQ

Here are the Form 4 insider transactions from Crexendo Inc (CXDO) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CXDO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CXDO filings page.

Rhea-AI Summary

Crexendo, Inc. director Kim L Jasmine reported compensation-related grants of stock options. She received stock options covering 10,000 shares of common stock with an exercise price of $6.47 per share that vest over 24 equal monthly installments beginning on April 5, 2024 and expire on March 5, 2026. A second grant covers 10,000 shares at $5.77 per share, vesting over 24 equal monthly installments beginning on April 5, 2025 and expiring on March 4, 2035. A third grant covers 15,000 shares at $5.36 per share, vesting over 36 equal monthly installments beginning on April 4, 2026 and expiring on March 5, 2034. These awards are reported as directly owned and reflect option grants rather than open-market share purchases or sales.

Rhea-AI Summary

Crexendo, Inc. Chief Revenue Officer Jon Brinton sold 10,000 shares of common stock in an open-market transaction at $9.65 per share. After the sale, he directly owned 104,795 shares. The transaction was executed under a pre-arranged Rule 10b5-1(c) trading plan entered on March 8, 2024, when he was not aware of material nonpublic information.

Rhea-AI Summary

Crexendo, Inc. Chief Operating Officer Douglas Walter Gaylor exercised stock options and sold shares of common stock. He exercised options for 6,000 shares of common stock at $2.72 per share and then sold 10,000 shares in an open-market transaction at $9.52 per share. After these transactions, he directly owned 227,413 shares of Crexendo common stock. The stock options referenced in the filing vest over 36 equal monthly installments beginning on 11/24/2022, indicating they are part of an ongoing equity compensation program.

Rhea-AI Summary

Crexendo, Inc. director-related holdings reported an open-market sale of Common Stock. A trust associated with director Steven G. Mihaylo sold 25,000 shares at $9.17 per share. Following this transaction, the trust’s indirect ownership stands at 11,216,771 shares of Crexendo common stock.

Rhea-AI Summary

Crexendo, Inc. Chief Financial Officer Vincent Ron reported an open-market sale of 1,450 shares of Common Stock at $9.75 per share. After this transaction, he directly holds 117,087 shares. The sale was executed under a pre-established Rule 10b5-1(c) trading plan entered into on December 9, 2024, indicating it was pre-planned rather than timed discretionarily.

Rhea-AI Summary

Crexendo, Inc. Chief Revenue Officer Jon Brinton reported an open-market sale of 10,000 shares of the company’s Common Stock at $9.14 per share. After this transaction, he directly holds 114,795 shares.

The sale was executed under a pre-arranged trading plan intended to comply with Rule 10b5-1(c), which was previously adopted while he was not aware of material nonpublic information. This indicates the sale followed a scheduled plan rather than a discretionary one.

Rhea-AI Summary

Crexendo, Inc. Chief Financial Officer Ron Vincent reported a series of transactions in Crexendo common stock. He sold a total of 62,539 shares in open-market transactions at weighted average prices around the high-$7 to mid-$9 range, under a pre-arranged Rule 10b5-1(c) trading plan entered on December 9, 2024.

In connection with equity compensation, 278 restricted stock units converted into the same number of common shares, while 77 shares were withheld on May 4, 2026 at a closing price of $8.17 to cover payroll taxes, which the company notes does not represent a sale by Vincent. He continues to hold Crexendo stock directly after these transactions.

Rhea-AI Summary

Crexendo, Inc.’s Chief Revenue Officer Jon Brinton reported an open-market sale of 114,795 shares of Common Stock at $9.14 per share. The transaction was executed as a planned trade under a Rule 10b5-1(c) plan entered on March 8, 2024. Following this sale, Brinton is shown as directly holding 114,795 shares of Crexendo common stock.

Rhea-AI Summary

Crexendo, Inc. Chief Executive Officer Jeffrey G. Korn reported multiple transactions in the company’s common stock. He completed open-market sales totaling 40,000 shares at prices of $9.00, $8.50 and $8.1565 per share, and now holds 208,615 shares directly. In connection with restricted stock units (RSUs), 278 RSUs were converted into common shares at a $0.00 exercise price, with 68 of those shares withheld to cover payroll taxes at a price of $8.17 per share; the filing notes this tax withholding does not represent a sale. After these transactions, he also holds 9,167 RSUs, which vest in equal monthly installments over 36 months starting on March 4, 2026, with delivery of shares upon vesting. One of the reported sales was carried out under a pre-arranged Rule 10b5-1(c) trading plan entered into on December 9, 2024.

Rhea-AI Summary

Crexendo, Inc. Chief Operating Officer Douglas Walter Gaylor reported a mix of stock sales, purchases, and equity compensation events involving Crexendo common shares. He sold 20,000 shares at a weighted average price of $9.3736 and 10,000 shares at $8.6601 in open‑market transactions, while purchasing 10,000 shares at $8.1541. A total of 77 shares were withheld at $8.17 on May 4, 2026 to cover payroll taxes, which the company notes does not represent a sale by him.

Gaylor also exercised 278 restricted stock units into an equal number of common shares, with each RSU representing one share upon vesting. Following these transactions, he holds 231,413 shares of common stock directly and 9,167 restricted stock units that vest in equal monthly installments over 36 months starting March 4, 2026. The filing notes that at least one sale was executed under a pre‑arranged Rule 10b5‑1(c) trading plan.

Rhea-AI Summary

Crexendo, Inc. Chief Operating Officer Douglas Walter Gaylor reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. He exercised derivative awards to acquire 832 shares of Crexendo common stock, while 229 shares were withheld by the company to cover payroll taxes.

The tax-withholding dispositions used closing stock prices of $6.19 and $6.82 per share, and the footnotes state these transactions do not represent sales by Gaylor. After these transactions, he directly held 270,810 shares of Crexendo common stock. The RSUs referenced in the filing vest in equal monthly installments over 36 months from various start dates, contingent on continued employment, with shares delivered upon vesting.

Rhea-AI Summary

Crexendo, Inc. Chief Executive Officer Jeffrey G. Korn reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. The filing shows exercises of RSUs into common stock alongside dispositions where the company withheld shares to cover payroll tax obligations at prices of $6.19 and $6.82 per share. Footnotes clarify these tax-withholding transactions do not represent open-market sales by the executive.

Rhea-AI Summary

Crexendo, Inc. Chief Financial Officer Vincent Ron reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. RSUs converted into a total of 832 shares of common stock through several derivative exercises at a stated price of $0.00 per share.

To cover payroll taxes upon vesting, the company withheld 229 shares of common stock, including 77 shares at $6.19 and 76-share blocks at $6.82, as noted in the footnotes. These tax-withholding dispositions are not open-market sales by the executive. Following the transactions, Ron directly holds 180,473 shares of Crexendo common stock, with additional RSUs scheduled to vest in equal monthly installments over 36 months under multiple grant schedules.

Rhea-AI Summary

Crexendo, Inc. Chief Financial Officer Vincent Ron reported routine equity compensation activity involving restricted stock units (RSUs). On March 25, 2026, RSUs covering 556 shares of common stock vested and were delivered, increasing his direct holdings. To cover associated payroll taxes, the company withheld 153 shares of common stock, valued using the $6.48 closing price, which the footnotes clarify does not represent a market sale. After these transactions, Ron directly holds 180,272 shares of Crexendo common stock.

Rhea-AI Summary

Crexendo, Inc. Chief Operating Officer Douglas Walter Gaylor reported routine equity compensation activity on March 25, 2026. He acquired 556 shares of common stock through the vesting and conversion of restricted stock units, which represent stock-based pay for continued employment.

To cover payroll taxes on these vestings, the company withheld 153 shares of common stock (76 and 77 shares) valued at $6.48 per share, which the footnotes clarify are not open‑market sales. After these transactions, he directly holds 270,609 shares of Crexendo common stock. The RSU awards vest in equal monthly installments over 36 months starting on March 25, 2025 and October 25, 2025, subject to continued employment.

Rhea-AI Summary

Crexendo, Inc. Chief Executive Officer Jeffrey G. Korn reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. On March 25, 2026, two RSU tranches covering 278 shares of common stock each, or 556 shares in total, were converted into common stock at an exercise price of $0.00 per share. To cover payroll taxes on these vestings, the company withheld 68 shares of common stock for each tranche, or 136 shares in total, valued at $6.48 per share based on the closing stock price that day; the footnotes state these withholdings do not represent sales by Korn. After these transactions, Korn directly owned 247,776 shares of Crexendo common stock.

Rhea-AI Summary

Crexendo, Inc. Chief Strategy Officer Anand Buch reported open-market sales of the company’s common stock. On March 11 and March 13, 2026, he sold a total of 88,000 shares in three open-market transactions at prices between $6.35 and $6.735 per share.

Following these sales, Buch directly owns 447,498 shares of Crexendo common stock, indicating he retains a substantial equity position even after the dispositions.

Rhea-AI Summary

Crexendo, Inc. director and 10% owner Steven G. Mihaylo reported open-market sales of a total of 64,994 shares of common stock, executed indirectly via a trust. The sales took place between March 6 and March 10, 2026 at prices ranging from $6.79 to $7.06 per share. Following these transactions, the trust’s indirect holdings stood at 11,241,771 shares of Crexendo common stock.

Rhea-AI Summary

Crexendo, Inc. Chief Technology Officer David Tzat-kin Wang reported open-market sales of company stock. On March 9, 2026, he sold 18,606 shares of Common Stock at an average price of $7.00 per share and a further 1,876 shares at $7.01 per share.

After these transactions, Wang directly holds 629,949 shares of Crexendo common stock. The filing reflects net sales of 20,482 shares and shows no related option exercises or derivative positions in this report.

Rhea-AI Summary

Crexendo, Inc. Chief Strategy Officer Anand Buch reported a mix of equity compensation activity and stock sales. On March 4–5, 2026, he exercised a total of 6,251 Restricted Stock Units into common shares, with 2,555 shares withheld by the company to cover payroll taxes; the footnotes clarify these tax-withholding dispositions are not sales. He also received a grant of 10,000 ISO stock options at an exercise price of $6.47 per share, vesting monthly through 2036. On March 10, 2026, Buch made open-market sales of 34,315 shares of common stock at prices of about $6.88 and $7.01 per share. After these transactions, he directly holds 535,498 shares of Crexendo common stock.

Rhea-AI Summary

Crexendo, Inc. director Todd Andrew Goergen reported stock-based transactions. On March 4, 2026 he received a grant of 10,000 stock options with an exercise price of $6.47 per share, expiring March 4, 2036; a footnote states these stock options vest over 36 equal monthly installments beginning April 4, 2026.

The filing also describes a prior net exercise on September 12, 2025 of options for 10,000 shares at $2.25 per share, in which he received 6,676 shares of common stock while 3,324 shares were withheld to pay the exercise price using a $6.77 stock price; the company notes this did not involve an open-market sale. After these transactions he directly holds 235,352 shares of common stock.

Rhea-AI Summary

Crexendo, Inc. director David Roy Williams reported receiving a grant of stock options. The award covers 10,000 stock options with an exercise price of $6.47 per share. According to the disclosure, these options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the director earns the right to exercise a portion of the options each month over three years. Following this grant, Williams is shown as holding 10,000 stock options directly.

Rhea-AI Summary

Crexendo, Inc. director Anil K. Puri reported receiving a grant of stock options for 10,000 shares at an exercise price of $6.47 per share. This is an acquisition of derivative securities rather than an open-market stock purchase.

The options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the award becomes exercisable gradually over three years, aligning Puri’s potential equity ownership with longer-term service to the company.

Rhea-AI Summary

Crexendo, Inc. director Kevin Arnold Jackson reported receiving a grant of stock options on March 4, 2026. The award covers 10,000 stock options with an exercise price of $6.47 per share, giving him the right to buy company stock at that price in the future.

According to the filing, these options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the award becomes exercisable gradually over three years rather than all at once. After this grant, he holds 10,000 stock options directly.

Rhea-AI Summary

Crexendo, Inc. director Chris McKee reported receiving a grant of stock options on March 4, 2026. The award covers 10,000 stock options with an exercise price of $6.47 per share, all held as direct ownership. The options vest over 36 equal monthly installments beginning on April 4, 2026, meaning the right to exercise builds gradually over three years rather than all at once.

Rhea-AI Summary

Crexendo, Inc. director and major shareholder Steven G. Mihaylo reported receiving a grant of stock options. The award covers 10,000 stock options at an exercise price of $6.47 per share. According to the disclosure, these options vest in 36 equal monthly installments starting on April 4, 2026, meaning the grant becomes exercisable gradually over three years rather than all at once.

Rhea-AI Summary

Crexendo, Inc. Chief Technology Officer David Tzat-kin Wang reported routine equity award activity. On March 4 and 5, 2026, he exercised restricted stock units, receiving a total of 5,001 shares of common stock at a price of $0.00 per share through derivative conversions.

To cover associated payroll taxes, the company withheld 868 shares at $6.47 on March 4 and 1,193 shares at $6.88 on March 5, which footnotes state do not represent sales by him. After these transactions, he directly owned 650,431 shares of Crexendo common stock. Footnotes also describe RSU grants that vest quarterly over 12 quarters beginning in 2024, 2025, and 2026, contingent on continued employment, with shares delivered upon vesting.

Rhea-AI Summary

Crexendo, Inc. Chief Revenue Officer Jon Brinton reported multiple equity compensation transactions. On March 4, 2026, he received a grant of 40,000 Restricted Stock Units (RSUs), which will vest in equal quarterly installments over 12 quarters starting on June 4, 2026, subject to continuous employment, with shares delivered upon vesting.

Brinton also exercised RSUs into common stock on March 4 and 5, 2026, converting 2,916 and 2,917 RSUs, respectively, into the same number of common shares at no exercise price. To cover associated payroll taxes, the company withheld 923 shares at $6.47 on March 4 and 843 shares at $6.88 on March 5; footnotes state these withholdings do not represent sales by Brinton. After these transactions, he directly held 124,795 shares of common stock and RSU awards as reported.

Rhea-AI Summary

Crexendo, Inc. Chief Operating Officer Gaylor Douglas Walter reported several equity compensation transactions. On March 4 and 5, 2026, he exercised multiple restricted stock unit (RSU) awards, converting them into shares of Crexendo common stock, including blocks of 70,000, 5,000, and 4,167 units.

In connection with these vested RSUs, the company withheld 1,368, 76, and 1,140 shares of common stock at prices of $6.47 and $6.88 per share to pay associated payroll taxes. Footnotes state these withholding transactions do not represent open‑market sales by the executive. Following the latest transactions, he directly owned 270,206 shares of Crexendo common stock.

Rhea-AI Summary

Crexendo, Inc. Chief Financial Officer Vincent Ron reported multiple equity compensation transactions involving restricted stock units (RSUs) and common stock. On March 4, 2026, he received a grant of 70,000 RSUs, which the footnotes state will vest in equal monthly installments over 36 months starting on March 4, 2026, with shares delivered upon vesting.

He also exercised previously awarded RSUs into common stock on March 4 and March 5, 2026, at a stated price of $0.00 per share, increasing his direct common share holdings. Following the last reported transaction on March 5, 2026, he directly owned 179,869 shares of Crexendo common stock.

On both dates, the company withheld portions of his common shares—1,368 shares at $6.47 and 1,140 shares at $6.88—to cover associated payroll taxes. The footnotes clarify that these tax-withholding transactions do not represent open-market sales by the reporting person.

Rhea-AI Summary

Crexendo, Inc. Chief Executive Officer Jeffrey G. Korn reported multiple equity award transactions. On March 4 and 5, 2026, he acquired common stock through the exercise or conversion of restricted stock units (RSUs), with several RSU grants scheduled to vest over quarterly or monthly periods, subject to continued employment.

The company withheld shares of common stock, including 1,218 shares at $6.47 and 1,218 shares at $6.88 per share, to cover payroll taxes; footnotes state these tax-withholding transactions do not represent sales by the reporting person.

Rhea-AI Summary

Crexendo, Inc. Chief Financial Officer Vincent Ron reported routine equity award activity involving restricted stock units and common stock. On February 25, 2026, he acquired 278 shares of common stock through derivative exercise/conversion transactions at $0.00 per share, reflecting RSUs settling into stock.

The company withheld 91 shares of common stock, using a closing price of $5.84, to pay associated payroll taxes, and the disclosure specifies these tax-withholding dispositions do not represent sales by Ron. After these transactions, he directly holds 173,009 shares of Crexendo common stock.

The RSUs referenced vest in equal monthly installments over 36 months starting on March 25, 2025 and October 25, 2025, subject to continuous employment, with one share of CXDO common stock delivered for each RSU upon vesting.

Rhea-AI Summary

Crexendo, Inc. Chief Executive Officer Jeffrey G. Korn reported routine equity compensation activity involving restricted stock units (RSUs) that vested into common shares on February 25, 2026. He acquired a total of 556 shares of common stock through derivative exercises converting RSUs into shares at a stated price of $0.00 per share.

In connection with these vesting events, the company withheld 82 shares and 83 shares of common stock, respectively, using a closing stock price of $5.84 on February 25, 2026 to cover associated payroll taxes. Footnotes clarify these withholdings are tax-related and do not represent open-market sales by the reporting person. Following the transactions, Korn directly held 239,582 shares of Crexendo common stock.

Rhea-AI Summary

Crexendo, Inc.’s Chief Operating Officer Douglas Walter Gaylor reported routine equity compensation activity. On February 25, 2026, he acquired common stock through the exercise and conversion of restricted stock units (RSUs), a non-cash transaction at a stated price of $0.00 per share.

The company withheld 91 shares of common stock in two separate transactions at a price of $5.84 per share to cover associated payroll taxes, and the footnotes state these withholdings do not represent sales by the reporting person. Following these transactions, Gaylor directly owned 263,346 shares of Crexendo common stock.

Footnotes explain that each RSU converts into one share of common stock upon vesting, and that the RSUs vest in equal monthly installments over 36 months starting on March 25, 2025 and October 25, 2025, subject to continuous employment, with shares delivered upon vesting.

Rhea-AI Summary

Crexendo, Inc. (CXDO) Chief Operating Officer Douglas Walter Gaylor reported an equity grant of 10,000 restricted stock units (RSUs). The RSUs were awarded on February 4, 2026 and each RSU represents the right to receive one share of Crexendo common stock upon vesting.

The 10,000 RSUs vest in equal monthly installments over 36 months starting on March 4, 2026, until they are fully vested, contingent on continued employment. Shares of common stock will be delivered as the RSUs vest. Following this grant, Gaylor beneficially owns 10,000 derivative securities directly.

Rhea-AI Summary

Crexendo, Inc. reported an insider equity award for its Chief Executive Officer, Jeffrey G. Korn. On February 4, 2026, he was granted 10,000 restricted stock units (RSUs) at a stated price of $0 per unit, held as a derivative security.

Each RSU represents the right to receive one share of CXDO common stock upon vesting, contingent on continued employment. The RSUs vest in equal monthly installments over 36 months, starting on March 4, 2026, until fully vested, with shares delivered upon each vesting date. Following this grant, he directly beneficially owns 10,000 derivative securities related to these RSUs.

Rhea-AI Summary

Crexendo, Inc. reported that its Chief Financial Officer, Ron Vincent, received a grant of 10,000 restricted stock units on February 4, 2026. Each RSU represents the right to receive one share of Crexendo common stock upon vesting, contingent on continued employment.

The RSUs vest in equal monthly installments over 36 months, starting on March 4, 2026, until they are fully vested. Following this grant, Vincent beneficially owns 10,000 derivative securities in the form of RSUs held directly.

Rhea-AI Summary

Crexendo, Inc. chief financial officer Ron Vincent filed an amended insider trading report detailing recent stock and RSU activity. On January 22, 2026, he sold 1,011 shares of common stock at $7.784 per share under a pre-arranged Rule 10b5-1(c) trading plan adopted on December 9, 2024. On January 25, 2026, 277 restricted stock units (RSUs) twice converted into common shares at a $0 exercise price, while the company withheld 90 and 91 shares at $7.45 per share to cover payroll taxes, which is not treated as a sale by Vincent. Following these transactions, he directly owned 172,635 shares of common stock and retained RSU balances of 6,946 and 8,890 units under separate vesting schedules. The amendment corrects an earlier filing that omitted the January 22, 2026 sale.

Rhea-AI Summary

Crexendo, Inc. reported insider equity activity by Chief Executive Officer Jeffrey G. Korn. On January 25, 2026, 277 restricted stock units (RSUs) twice converted to common stock at an exercise price of $0, reflecting scheduled vesting tied to continued employment.

To cover payroll taxes on these vestings, the company withheld 82 shares and 83 shares of common stock using the $7.45 closing stock price on January 25, 2026; these withholdings are explicitly stated not to be sales by the executive. The underlying RSU grants vest in equal monthly installments over 36 months starting on March 25, 2025 and October 25, 2025, with shares delivered as they vest.

Rhea-AI Summary

Crexendo Chief Financial Officer Ron Vincent reported routine equity compensation activity. On January 25, 2026, 554 restricted stock units vested and were converted into an equal number of Crexendo common shares at an exercise price of $0 per share.

To cover payroll taxes, the company withheld 90 shares and 91 shares at a closing stock price of $7.45, and the footnotes state these withholdings do not represent sales by Vincent. Following these transactions, he beneficially owned 173,646 shares of Crexendo common stock directly.

Rhea-AI Summary

Crexendo, Inc. Chief Operating Officer Douglas Walter Gaylor reported routine equity compensation activity involving restricted stock units (RSUs) and common stock on January 25, 2026.

Two RSU tranches of 277 units each were converted into an equal number of Crexendo common shares at an exercise price of $0, reflecting normal vesting of previously granted awards. Following these transactions, he directly held 262,972 shares of common stock, according to the filing.

The company withheld 90 shares and 91 shares of common stock, respectively, at a price of $7.45 per share to cover associated payroll taxes. The footnotes clarify that these withholding transactions do not represent sales by the reporting person but are tax-settlement events tied to the vesting RSUs. The RSUs vest in equal monthly installments over 36 months from March 25, 2025 and October 25, 2025, contingent on continued employment, with shares delivered upon vesting.

Rhea-AI Summary

Crexendo, Inc. director David Roy Williams reported a net exercise of stock options and an increase in his common share holdings. On January 15, 2026, he exercised 10,000 non-qualified stock options at an exercise price of $2.25 per share, receiving common stock instead of cash.

According to the footnote, this was a “net exercise”: Williams received 6,951 shares of common stock, while the company withheld 3,049 shares to cover the exercise price using the $7.38 closing stock price on that date. The filing states this does not represent a sale by Williams. After these transactions, he directly owns 41,085 shares of Crexendo common stock.

Rhea-AI Summary

Crexendo, Inc. director and 10% owner Steven G. Mihaylo reported a net exercise of stock options and related share withholding. On January 14, 2026, he exercised incentive stock options to purchase 13,408 shares of Crexendo common stock at an exercise price of $2.25 per share. According to the footnote, he received 9,200 shares of common stock, while the company withheld 4,208 shares to cover the exercise price using the closing stock price of $7.17 on January 14, 2025.

After these transactions, Mihaylo directly owned 11,306,765 shares of Crexendo common stock. The footnote states that the share withholding “does not represent a sale” by the reporting person, meaning the reduction in shares was used solely to pay the option exercise cost rather than to sell shares into the market.

Rhea-AI Summary

Crexendo, Inc. director Anil K. Puri net exercised stock options for 10,000 shares of common stock on January 12, 2026. The options had an exercise price of $2.25 per share and were fully exercised, leaving no options remaining.

On net exercise, he received 6,696 shares of common stock, while 3,304 shares were withheld by the company to pay the exercise price using the closing stock price of $6.81 on January 12, 2026. This withholding is explicitly stated as not representing a sale by the reporting person. Following these transactions, Puri directly owned 56,514 shares of Crexendo common stock.

Rhea-AI Summary

Crexendo, Inc. Chief Operating Officer Douglas Walter Gaylor reported an option exercise on January 12, 2026. He exercised 12,000 stock options at an exercise price of $2.25 per share, receiving 12,000 shares of common stock. Following the transaction, he directly owned 262,599 shares of Crexendo common stock. The related stock option grant, which vested over 36 equal monthly installments beginning March 12, 2019, now shows 0 derivative securities beneficially owned after this exercise.

Rhea-AI Summary

Crexendo Chief Revenue Officer Jon Brinton reported routine equity transactions related to restricted stock units. On December 4 and 5, 2025, RSUs vested into 2,917 and 2,916 shares of common stock, respectively, at an exercise price of $0, increasing his direct holdings.

On each vesting date the company withheld 769 shares to cover payroll taxes, using closing stock prices of $6.71 and $6.64, and these withholdings are described as not sales by the reporting person. Following the reported transactions, Brinton directly owned 120,728 shares of Crexendo common stock and continued to hold 26,250 and 14,584 restricted stock units that vest in equal quarterly installments over 12 quarters, subject to continued employment.

Rhea-AI Summary

Crexendo, Inc.’s Chief Financial Officer, Ron Vincent, reported changes in his ownership of CXDO common stock from restricted stock unit (RSU) vesting and related tax withholding. On December 4, 2025, 5,000 shares were acquired at $0 upon RSU vesting, and 1,368 shares were withheld by the company to cover payroll taxes at a closing price of $6.71. On December 5, 2025, an additional 4,166 shares vested at $0, and 1,140 shares were withheld at $6.64; the filing states these withholding transactions do not represent sales.

Following these transactions, Vincent directly beneficially owned 172,870 shares of Crexendo common stock. He also continues to hold 45,000 RSUs that vest in equal quarterly installments over 12 quarters starting on June 4, 2025, and 20,834 RSUs vesting in equal quarterly installments over 12 quarters starting on June 5, 2024, in each case contingent on continued employment, with shares delivered upon vesting.

Rhea-AI Summary

Crexendo, Inc. (CXDO) Chief Financial Officer reported routine equity compensation activity involving restricted stock units (RSUs). On November 25, 2025, 278 shares of common stock were delivered upon vesting of RSUs, and the company withheld 77 shares at a price of $6.96 per share to cover payroll taxes. A second block of 278 shares was delivered the same day from another RSU grant, with 76 shares withheld at $6.96 for taxes. The reporting person held 166,212 shares of common stock directly after these transactions, along with 7,501 and 9,445 RSUs that continue to vest in equal monthly installments over 36 months starting on March 25, 2025 and October 25, 2025, respectively, subject to continued employment.

Rhea-AI Summary

Crexendo, Inc. (CXDO) CEO equity update: The Chief Executive Officer reported multiple transactions on 11/25/2025 involving restricted stock units (RSUs) and related common stock. RSU awards converted into common stock in blocks of 278 shares at an exercise price of $0, reflecting vesting of previously granted RSUs. To cover payroll taxes, the company withheld 68 shares of common stock at a closing stock price of $6.96, which is stated as not representing a sale by the reporting person. Following these transactions, the CEO beneficially owned 230,818 shares of Crexendo common stock directly. The RSUs underlying these transactions vest in equal monthly installments over 36 months from March 25, 2025 and October 25, 2025, contingent on continued employment, with shares delivered upon vesting.

Rhea-AI Summary

Crexendo, Inc. (CXDO) Chief Operating Officer Douglas Walter Gaylor reported routine equity compensation activity. On November 25, 2025, 278 restricted stock units (RSUs) converted into common stock at an exercise price of $0, and the company withheld 77 shares of common stock at $6.96 per share to cover payroll taxes. A second block of 278 RSUs converted the same day, with 76 shares withheld at $6.96 for taxes.

Following these transactions, Gaylor beneficially owned 243,538 shares of Crexendo common stock directly. He also held 7,501 RSUs that vest in equal monthly installments over 36 months starting on March 25, 2025, and 9,445 RSUs that vest in equal monthly installments over 36 months starting on October 25, 2025, in each case contingent on continued employment, with shares delivered as they vest.